In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...

March 15, 2005 (Orlando) — Results of the Prospective Evaluation of EECP in Congestive Heart Failure (PEECH) trial, announced here during the American College of Cardiology 2005 Annual Scientific ...

Enhanced External Counterpulsation (EECP) is a unique outpatient, noninvasive treatment method currently used to improve myocardial perfusion, reduce symptoms from obstructive coronary disease, and ...

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest ...

PITTSBURGH, Feb. 27 – Patients with angina (chest pain) and left ventricular dysfunction respond very well to treatment using enhanced external counterpulsation (EECP), with little or no future heart ...

WESTBURY, N.Y.--(BUSINESS WIRE)--March 10, 2006--Vasomedical, Inc. (Nasdaq SC: VASO), a leader in the noninvasive treatment and management of cardiovascular diseases, reconfirmed that the majority of ...

Enhanced External Counterpulsation (EECP) is a non-invasive therapeutic modality that applies sequential pneumatic compression to the lower limbs in synchrony with the cardiac cycle. By augmenting ...

Kaleida Health has begun offering a noninvasive technique to improve heart functioning in patients. The therapy, called enhanced external counterpulsation (EECP), squeezes blood up from the legs when ...

Vasomedical, Inc. (NASDAQSmallCap: VASO), announced today that five major third-party payers in the United Kingdom have expanded their reimbursement structures to include EECP external ...

From Anaheim, Calif., at the American Heart Association’s Scientific Sessions 2001. In many patients, a therapy in which inflatable cuffs placed on each leg squeeze blood back up to the heart can ...